As CorTec grows and pursues novel therapeutic applications together with partners, the attendant regulatory, quality assurance, and clinical complexities facing the business increase. We are therefore pleased to announce that Claus Freyinger has joined CorTec in the position of Chief Regulatory & Clinical Officer as of September 1, 2021, relocating from San Francisco, CA to Freiburg, Germany.
Claus brings over 20 years of med-tech industry experience at multinational med-tech leaders like Stryker, Medtronic, Sorin CRM, as well as stints with an EU Notified Body and several med-tech start-ups.
“I am excited to join CorTec in this new role as we look to enable novel neurostimulation therapies, and in particular develop the Brain Interchange Platform technology, which promises to enable treatment of underserved patients with diverse neurological and neurodegenerative pathologies, such as Parkinson’s Disease, epilepsy, and stroke rehabilitation”, says Claus Freyinger.
His experience includes functional leadership in the areas of regulatory affairs, quality assurance, and market access & reimbursement, with a focus on high risk, implantable products in the neurovascular and cardiovascular sectors.
Areas of demonstrated success for Claus include leading global teams, strategic and tactical initiatives including time-to-market acceleration, and regulatory advocacy & clinical affairs activities globally. His educational background includes degrees from Boston College, executive education from Kellogg School of Management (Chicago), and a Certificat d’Etudes Politiques from “Sciences Po” (Strasbourg, France).
We are happy to welcome Claus as a new member of the CorTec team and we are looking forward to further expansion and an exciting future together.
You would like to gain more insights about our daily working life at CorTec or would like to become part of our team?